Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management | MicrobiomeTrials← Back to trialsNCT07322549
Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management
CompletedOBSERVATIONAL
Trial Details
Start: 2025-03-01Est. Completion: 2025-09-30
Enrollment target: 104 participants Locations- Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, Var, France
Other microbiome trials you might be interested in
Community Acquired PneumoniaChildhood Pneumonia
Pneumonia is the most common infection in children and leading to most common cause of mortality and morbidity in in chi…
Peshawar, PakistanEst. completion Jun 1, 2027
Anemia, Sickle Cell
The purpose of this study is to find out whether siplizumab is safe and effective for patients with SCD undergoing an al…
New York, United StatesCompleted Dec 11, 2024